Latest News and Press Releases

Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The "Primary Care Physicians Market in US 2024-2028" report has been added to ResearchAndMarkets.com's offering.The primary care physicians market in US is...

Dublin, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The "Trend Opportunity Profile Series Health, Wellness, and Nutrition (4th Edition)" report has been added to ResearchAndMarkets.com's offering.This report...

SAN FRANCISCO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- (Oct. 8, 2024) – Sutter Health announced today researchers at its Sequoia Center for the Science of Aging will receive $21 million from a $67.7...

The Columbus Organization appoints Melissa Koontz as Regional VP of Care Coordination to align with ongoing nationwide growth.

Io Therapeutics, Inc., presented on IRX4204 for treatment of brain aging, at the FASEB Conference on Cellular and Molecular Mechanisms of Brain Aging

Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "Healthcare Fabrics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Healthcare...

Sensi.AI's Care Intelligence Research Finds Surprising Revelations Around Crucial Gaps In Senior Care at Nights and Weekends

BOSTON , Aug. 08, 2024 (GLOBE NEWSWIRE) --  HouseWorks Holdings, LLC (the “Company”), a leading personal care services platform serving the Northeast, announces that it has acquired Bridge City Home...

Dublin, July 16, 2024 (GLOBE NEWSWIRE) -- The "The 2024 U.S. Post-Acute Market Report" report has been added to ResearchAndMarkets.com's offering. The U.S. post-acute market is expected to reach...

Io Therapeutics presented data on the potential of IRX4204 for treatment of aging-related neurodegeneration, Parkinson's disease, and Alzheimer's disease